Telix Pharmaceuticals | Betriebsaufwand



Operating Expenses Veränderung Datum
Cochlear AUD 897.2M 19.8M 2024-12
CSL USD 5.72B 173M 2024-12
Integral Diagnostics AUD 219.16M 66.76M 2024-06
Mayne Pharma AUD 103.54M 9.39M 2024-06
Medical Developments International AUD 19.8M 9.46M 2024-12
Mesoblast 48.24M 21.34M 2024-06
Neuren Pharmaceuticals AUD 17.41M 2.86M 2024-12
Pacific Edge NZD 26.27M 12.77M 2024-09
Paradigm Biopharmaceuticals AUD 6.36M 8.6M 2024-12
Polynovo AUD 27.51M 19.08M 2024-06
PYC Therapeutics AUD 38.58M 20.29M 2024-12
Ramsay Health Care AUD 8.35B 258.6M 2024-12
ResMed USD 864.85M 27.65M 2024-12
Sonic Healthcare AUD 4.23B 2.14B 2024-12



Telix Pharmaceuticals Betriebsaufwand - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Jun 2025.